Previous studies have shown that TrpA1 channels can be activated via indirect mechanisms resulting from the change in inflammation, oxidative stress, and mitochondrial toxicity associated with chronic exposure to anti-cancer drugs [8,11,41,42,74,75]. Here, TRPA1 is linked to cancer.